Tolaney SM, Wardley AM, Zambelli S, Hilton JF, et al. Abemaciclib plus trastuzumab with or without fulvestrant versus trastuzumab plus standard-of-care chemotherapy in women with hormone receptor-positive, HER2-positive advanced breast cancer (monarcHER): a randomised, open-label, phase 2 trial. Lancet Oncol 2020 Apr 27. pii: S1470-2045(20)30112.
PMID: 32353342